DEBIOPHARM GROUP
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.
DEBIOPHARM GROUP
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
1979-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.debiopharm.com
Total Employee:
251+
Status:
Active
Contact:
+41213210111
Total Funding:
4.7 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Amazon ASP.NET IIS Amazon Virginia Region Java EE Lorem Ipsum WordPress 5.8 Apple Whitelist IIS 7
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Nanoform Therapeutics
Nanoform Therapeutics develops new generation of Bio-Pharmaceutical developmental or marketed drugs.
Current Employees Featured
Thierry Mauvernay President & Delegate of the Board @ Debiopharm Group
President & Delegate of the Board
Sophie Genecand Director, Real Estate department, Debiopharm Investment S.A. @ Debiopharm Group
Director, Real Estate department, Debiopharm Investment S.A.
ANGELA ZUBEL Chief Development Officer @ Debiopharm Group
Chief Development Officer
2019-02-01
Bertrand Ducrey CEO @ Debiopharm Group
CEO
2012-01-01
Raymond Zaugg Director, Financial department, Debiopharm Investment S.A @ Debiopharm Group
Director, Financial department, Debiopharm Investment S.A
Riccardo Nisato Licensing and Grants Associate Manager @ Debiopharm Group
Licensing and Grants Associate Manager
2021-04-01
Alexandra Le Coz Sanchez Associate Director, Private Equity Department, Debiopharm Investment S.A. @ Debiopharm Group
Associate Director, Private Equity Department, Debiopharm Investment S.A.
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-02-11 | Affinium Pharmaceuticals | Affinium Pharmaceuticals acquired by Debiopharm Group | N/A |
Investors List
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-01-09 | Novadiscovery | Debiopharm Group investment in Series A - Novadiscovery | 5 M EUR |
| 2019-11-10 | Little Green House | Debiopharm Group investment in Corporate Round - Little Green House | N/A |
| 2016-10-26 | Coorpacademy | Debiopharm Group investment in Series B - Coorpacademy | 10 M EUR |
| 2015-04-03 | Immunexpress | Debiopharm Group investment in Debt Financing - Immunexpress | 40 M USD |
| 2014-11-17 | Coorpacademy | Debiopharm Group investment in Series A - Coorpacademy | 3.2 M EUR |
| 2014-05-05 | Immunexpress | Debiopharm Group investment in Series B - Immunexpress | 18 M USD |
| 2014-03-05 | Immunexpress | Debiopharm Group investment in Funding Round - Immunexpress | 6 M USD |
| 2013-12-03 | BPA Solutions | Debiopharm Group investment in Funding Round - BPA Solutions | N/A |
| 2013-09-06 | Skioo | Debiopharm Group investment in Venture Round - Skioo | N/A |
| 2013-05-22 | Urturn | Debiopharm Group investment in Series A - Urturn | 13.4 M USD |
Newest Events participated
Participated in Swiss Startup Day
on 2015-10-21 as sponsor
Official Site Inspections
http://www.debiopharm.com Semrush global rank: 4.77 M Semrush visits lastest month: 1.93 K
- Host name: havps24.iron.bsa.oriented.ch
- IP address: 185.15.230.34
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Debiopharm Group"
Debiopharm - Wikipedia
Debiopharm is a privately-held Swiss biopharmaceutical company mainly active in development and clinical testing of drug candidates. [1] It was founded in 1979 by Rolland-Yves Mauvernay. …See details»
Debiopharm Group - Crunchbase Company Profile
Debiopharm Group may be growing as it has provided additional funding to MedaSystems, which indicates an increase in investment activities. This …See details»
Leadership Team - Debiopharm
Debiopharm, with 15 ongoing drug research programs, has developed two blockbuster therapies for cancer patients, oxaliplatin and triptorelin, along with a potential 3rd Head & Neck Cancer …See details»
Drug Development - Debiopharm
Debiopharm is an innovation-focused, Swiss biopharmaceutical company that aims to develop novel therapies to target high unmet medical needs in oncology and infectious diseases. We establish partnerships with academic, biotech, …See details»
Debiopharm - Org Chart, Teams, Culture & Jobs - The …
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out …See details»
Debiopharm Group - Funding, Financials, Valuation & Investors
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug. New. Resources. Advanced Search. ... How much funding …See details»
Debiopharm S.A. - life-sciences-asia.com
Debiopharm Group™ is a Swiss-based global biopharmaceutical group of five companies active in the development and manufacture of drugs and diagnostics tools. Debiopharm focuses on …See details»
Debiopharm International SA - Swiss Biotech
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug …See details»
Debiopharm - Company-Profile | PDF | Drug …
Debiopharm Innovation Fund SA Debiopharm Innovation Fund is the strategic investment fund of the Debiopharm Group. We invest in young innovative companies in the following areas: • Smart data (pilot or early commercial …See details»
Debiopharm and Oncodesign Services Launch Strategic …
7 hours ago Debiopharm Research & Manufacturing Contact: Dawn Bonine – Head of Communications Dawn.bonine@debiopharm.com Tel: +41 (0)21 321 01 11 Oncodesign …See details»
Debiopharm Innovation Fund - Crunchbase
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs …See details»
Debiopharm - 2025 Company Profile, Funding & Competitors
Apr 8, 2025 Debiopharm is a funded company based in Lausanne (Switzerland), founded in 1979 by Rolland Yves Mauvernay. It operates as a Biopharmaceutical company focused on …See details»
Debiopharm - Overview, News & Similar companies | ZoomInfo.com
LAUSANNE, Switzerland & BARCELONA, Spain--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming …See details»
Debiopharm - Swiss Biotech
Family-owned Debiopharm from Lausanne, identifies high-potential compounds in oncology and for the treatment of bacterial infections. They are tested in clinical development and licensed to …See details»
Debiopharm to Reveal Insights From Their ADC, DDR Inhibitor, …
1 day ago LAUSANNE, Switzerland, April 22, 2025--Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s …See details»
MEDSIR & Debiopharm Announce the First Patient Dosed in the
Feb 26, 2025 LAUSANNE, Switzerland & BARCELONA, Spain--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical …See details»
Debiopharm and Oncodesign Services Launch Strategic …
6 hours ago Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer and infectious …See details»
10 Report on Debiopharm - bio-xcelerator.com
Eugene Consulting Inc. 1602- 111 St. Clair Ave W Toronto, ON M4V 1N5 Awards and Grants • The JCA-Mauvernay Award • Launched in 2005, the Japanese Cancer Association (JCA) and …See details»
Pipeline - Debiopharm
Hallmarks targeted by Debiopharm development programs. Prevention of sustained proliferative signaling . Cancer cells multiply by altering growth-promoting signals and becoming …See details»
Debiopharm Information - RocketReach
The NAICS codes for Debiopharm are [42421, 325, 32, 42, 424, 4242]. What is the SIC code for Debiopharm? The SIC codes for Debiopharm are [807, 80, 28, 283]. Top Debiopharm …See details»